Finding a clinical trial for a cancer patient demands extraordinary effort as it requires evaluating many available trial opportunities against specific patient characteristics. Ancora.ai accelerates clinical trial recruitment by systematically and seamlessly connecting patients to trials. Our proprietary technology structures jargon-laden clinical trial protocols into an easy to use interface to match any patient to trials at scale. Our best-in-class trial matching solution means we can more efficiently and effectively match highly qualified patients to the right trials, thereby transforming the $44B. clinical research industry to be data-driven & enabling precision medicine recruitment.
Location: Switzerland, Zurich
Investors 1
Date | Name | Website |
30.01.2024 | VentureLab | venturelab... |
Mentions in press and media 7
Date | Title | Description |
31.10.2024 | Startups überzeugen in ihren Branchen | Die Netzwerk-Organisation Swiss Healthcare Startups SHS hat erneut zum Digital Health Day nach Zürich eingeladen. Der Anlass avanciert zur führenden Gesundheitsveranstaltung für Startups und Innovatoren in der Schweiz. Der Tag soll Einblic... |
14.12.2023 | Ten startups join the 2024 roadshow in Barcelona | |
26.09.2023 | Future of Health Grant kicks off with new cohort | |
12.09.2023 | Four Swiss startups enter the DayOne Health 4.0 Accelerator | |
16.12.2021 | Ancora completes pre-seed round | |
18.11.2021 | Las 65 empresas partner de BIND 4.0 eligen 79 startups como finalistas de la sexta edición | 18/11/2021 Nota de prensa LAS 65 EMPRESAS PARTNER DE BIND 4.0 ELIGEN 79 STARTUPS COMO FINALISTAS DE LA SEXTA EDICIÓN. La plataforma de innovación abierta, BIND 4.0, acaba de publicar la lista de las 79 startups finalistas de su sexta edi... |
21.10.2020 | Healthtech and greentech dominate the DT50 startup awards | The winners of the 2020 DT50 awards have been chosen, and the field was led by healthtech and greentech startups. Even before the coronavirus pandemic struck, healthtech has been one of the hottest areas for European startups. But since Feb... |